The RAPS website will be under maintenance starting at 5 pm Eastern on Friday, October 1, 2021 until 8 am on Monday, October 4, 2021.
Portions of the website may be inaccessible during this time. We apologize for any inconvenience.

  • Regulatory NewsRegulatory News

    Canada Reimbursement Profile

    This profile summarizes reimbursement processes in Canada, presents information for key stakeholders and highlights what should be considered early in the development process. Obtaining regulatory approval for medicines is the first major hurdle of most pharmaceutical and biotechnology companies looking to launch their products worldwide. However, obtaining market access once products are approved by regulatory agencies (e.g., Health Canada) is a separate and crucial p...
  • Regulatory NewsRegulatory News

    Canada Proposes to Amend Drug Pricing Regulations

    For the first time in more than two decades, Canada’s government is looking to amend its drug pricing regulations to better protect Canadians from paying excessive prices for patented drugs. The move comes as the US government is undergoing a similar review of ways to bring down the price of drugs in the US, though one major difference between the neighbors is that Canada’s government has a means by which it can control the price of medicines. The US Congress is als...